scholarly journals The Main Effects of MiFID on European Capital Markets and European Integration

2020 ◽  
pp. 242-256
Author(s):  
Athanasios Panagopoulos
Keyword(s):  
Member State ◽  
European Integration ◽  
Capital Markets ◽  
Regulatory System ◽  
Legal Reforms ◽  
European Directive ◽  
Cross Border ◽  
Country Level ◽  
European Regulatory ◽  
Main Effects

This chapter researches whether the application of European Directive MiFID had any significant effects on the European Capital Markets and the progress of the European Integration. This new regulation specifies the tasks and responsibilities of the supervisory authorities of the Member State of origin and the host Member State, to enhance the certainty of effectiveness of cross border transactions supervision and to reduce the risk of imposing unnecessary legal reforms from the host Member State on investment firms which perform cross border transactions. The author concludes, among others, that the aligning of the national regulatory approaches to a common European regulatory system is quite necessary. MiFID will contribute to reduce problems at country level as the previous experience of the Investment Services Directive, where the European investments and economies of Member States were based mainly on the level of “country” and not of the “sector”.

scholarly journals The Main Effects of MiFID on European Capital Markets and European Integration

2015 ◽  
Vol 6 (5) ◽  
Author(s):  
Athanasios G. Panagopoulos ◽  
Thomas Chatzigagios ◽  
Ioannis Dokas
Keyword(s):  
European Integration ◽  
Capital Markets ◽  
Main Effects

The Wall Around EU Fundamental Freedoms: the Purely Internal Rule at the Forty-Year Mark

2019 ◽  
Vol 38 ◽  
pp. 153-219
Author(s):  
Amedeo Arena
Keyword(s):  
Member State ◽  
European Integration ◽  
Internal Market ◽  
European Court Of Justice ◽  
Integration Process ◽  
Cross Border ◽  
Fortieth Anniversary ◽  
Court Of Justice ◽  
European Court ◽  
Fundamental Freedoms

Abstract ‘Purely internal situations’ are sets of facts entirely confined within a single Member State. According to the ‘purely internal rule’, introduced by the European Court of Justice (ECJ) in 1979, purely internal situations lie outside the scope of the internal market fundamental freedoms and of other EU provisions having a cross-border scope. On the fortieth anniversary of the jurisprudential genesis of the purely internal rule, this article seeks to examine its origins, rationale, and evolution, by analyzing the most relevant patterns in the over 250 preliminary rulings handed down in disputes involving purely internal situations. This survey will enable an assessment of the systemic significance of the purely internal rule and of the consequences that abolishing that rule would have for the European integration process.

Estimating efficiency of Directive 2011/24/EU cross-border healthcare in member states

2018 ◽  
Vol 7 (8) ◽  
pp. 827-834
Author(s):  
Mustapha D Ibrahim ◽  
Mevhibe B Hocaoglu ◽  
Berna Numan ◽  
Sahand Daneshvar
Keyword(s):  
Member State ◽  
Healthcare Policy ◽  
Data Envelopment ◽  
Member States ◽  
Eu Member States ◽  
Patients Rights ◽  
Cross Border ◽  
Country Level ◽  
Using Data ◽  
Patients Experience

Aim: Directive 2011/24/EU on patients’ rights in cross-border healthcare facilitates EU citizens' access to and reimbursement for healthcare provided or prescribed in a member state other than the member state of affiliation. Materials & methods: The efficiency of cross-border healthcare policy is evaluated using data envelopment analysis of relevant items in Eurobarometer Survey on Safety and Quality of Care and Patients’ Rights in the EU. Results: Our study shows policy inefficiency in 52% of the 25 EU member states included in the analysis. Addressing difficulties patients encounter while seeking reimbursement from their national health service or health insurer and reducing the number of adverse events patients experience when receiving healthcare improves policy efficiency. Conclusion: Our findings confirm that there is country-level variation in cross-border healthcare policy efficiency.

Capital Markets Union after Brexit

2018 ◽  
Author(s):  
Danny Busch ◽  
Emilios Avgouleas ◽  
Guido Ferrarini
Keyword(s):  
Capital Markets ◽  
Action Plan ◽  
Economic Perspective ◽  
Institutional Investment ◽  
Fully Integrated ◽  
Cross Border ◽  
Better Regulation ◽  
Capital Markets Union ◽  
To Come ◽  
General Aspects

In line with the European Commission's wish to create fully integrated European capital markets, its Capital Markets Union (CMU) Action Plan is intended to make it easier for providers and receivers of funds to come into contact with one another within Europe, especially across borders. This book discusses various aspects of CMU from a legal and/or economic perspective. The chapters are grouped in a thematic way, covering the following areas: (i) general aspects, (ii) Brexit, (iii) financing innovation, (iv) raising capital on the capital markets, (v) fostering retail and institutional investment, (vi) leveraging banking capacity to support the wider economy, and (vii) facilitating cross-border investing. This chapter outlines some general aspects of CMU that are not explicitly covered by the other chapters in this book: (1) the CMU objectives, (2) the EBU–CMU relationship, (3) regulatory burden, and (4) Better Regulation and the Call for Evidence.

scholarly journals Adverse Drug Reaction Reporting by Patients in 12 European Countries

2021 ◽  
Vol 18 (4) ◽  
pp. 1507
Author(s):  
Agne Valinciute-Jankauskiene ◽  
Loreta Kubiliene
Keyword(s):  
Statistical Analysis ◽  
Adverse Drug Reaction Reporting ◽  
Regulatory System ◽  
European Countries ◽  
Pharmacovigilance System ◽  
Common Source ◽  
Patient Reporting ◽  
Safety Risks ◽  
European Regulatory ◽  
National Competent Authorities

Patients who report suspected adverse drug reactions (ADRs) help minimize drug safety risks and bolster the pharmacovigilance system. The aim of this study was to examine the contribution of patients to pharmacovigilance and compare the tools used to promote patient reporting in European countries that implemented this reporting type in 2012–2013. A web-based questionnaire was sent to the national competent authorities (NCAs) of the European countries. The received answers were systematized and compared using statistical analysis. The performed statistical analysis demonstrated that changes in the number of received ADR reports increased significantly in each country during the analyzed period. These changes were significantly different in Ireland and Finland from those in the other reviewed countries. The common source of information on direct patient reporting was the country’s NCA website. Other sources used were social media pages, leaflets, and posters. This is the first study on patient reporting schemes implemented after the significant reform of the European regulatory system for pharmacovigilance. However, some countries did not actively promote their patient reporting schemes. Our findings indicate that countries with minimal experience in pharmacovigilance systems that include direct patient reporting should organize comprehensive campaigns on ADR reporting.

A Social Enterprise Company in EU Organisational Law?

2021 ◽  
pp. 1-35
Author(s):  
J S LIPTRAP
Keyword(s):  
European Integration ◽  
European Commission ◽  
Social Enterprise ◽  
Social Economy ◽  
Member States ◽  
Regulatory Issues ◽  
Cross Border ◽  
The Social ◽  
Proposal A

Abstract This article explores the European Parliament's July 2018 non-legislative resolution proposing to the European Commission a directive for facilitating social enterprise companies’ cross-border activities. The proposal is first situated within the context of the social economy and how the sector has grown in importance to European integration. The proposal and the European Commission's response are then examined. Although the European Commission was not convinced that Member States would be amenable to the proposal, a consensus may already exist that is sufficient to garner their support. Even if this prediction is wrong, however, it is argued that there are reasons to surmise that the proposal will likely be reassessed and ultimately successful at some future point. Finally, the proposal is viewed with a reflexive harmonisation lens. Through the analysis, regulatory issues are identified, and a solution is then suggested.

A Small Member State and European Foreign Policy: Shaping or Taking? The Case of Belgium and the African Great Lakes

2008 ◽  
Vol 3 (3) ◽  
pp. 233-252 ◽  
Author(s):  
Skander Nasra
Keyword(s):  
Foreign Policy ◽  
Member State ◽  
Great Lakes ◽  
European Integration ◽  
Integration Process ◽  
Policy System ◽  
African Great Lakes ◽  
Foreign Policies ◽  
Small Member

AbstractThe European integration process has altered the conditions under which national foreign policies in Europe are made. Departing from this assumption, this article explores whether and under what conditions a small EU member state can influence European foreign policy. To this end, the role that Belgium has played in the construction of European foreign policy towards the African Great Lakes is examined. This article argues that a small EU member state can significantly influence European foreign policy, resulting in reinforcement of its national foreign policy. Yet this influence is conditioned by two intertwined factors: the nature of EU involvement; and the characteristics of the Union's foreign policy system. Depending on these elements, a small member state can supersede the quantifiable notion of 'smallness' and actively shape the construction of European foreign policy.

Sign in / Sign up

Export Citation Format

Share Document